Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
Statistics in Medicine · 2025
DOI: 10.1002/sim.70202 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Statistics in Medicine, 2025. Verfasst von David S Robertson und 6 weiteren Autor:innen. Beteiligte Einrichtung: MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Research Design, Adaptive Clinical Trials as Topic. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, HCRW_, Cancer Research UK.
Abstract (Originalsprache)
In adaptive clinical trials, the conventional confidence interval (CI) for a treatment effect is prone to undesirable properties such as undercoverage and potential inconsistency with the final hypothesis testing decision. Accordingly, as is stated in recent regulatory guidance on adaptive designs, there is the need for caution in the interpretation of CIs constructed during and after an adaptive clinical trial. However, it may be unclear which of the available CIs in the literature are preferable. This paper is the second in a two‐part series that explores CIs for adaptive trials. Part I provided a methodological review of approaches to construct CIs for adaptive designs. In this paper (Part II), we present an extended case study based around a two‐stage group sequential trial, including a comprehensive simulation study of the proposed CIs for this setting. This facilitates an expanded description of considerations around what makes for an effective CI procedure following an adaptive trial. We show that the CIs can have notably different properties. Finally, we propose a set of guidelines for researchers around the choice of CIs and the reporting of CIs following an adaptive design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
- University of Bath, Bath, UK.
- MRC Clinical Trials Unit at UCL, London, UK.
- Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, UK.
- Statistics and Decision Sciences, Janssen R&D, High Wycombe, UK.
- Centre for Trials Research, Cardiff University, Cardiff, UK.
ORCID-Profile: David S Robertson, Thomas Burnett, Babak Choodari-Oskooei
Förderung
- Medical Research Council
- HCRW_
- Cancer Research UK
- Health and Care Research Wales
Zitieren
APA
Robertson, D. S., Burnett, T., Choodari-Oskooei, B., Dimairo, M., Grayling, M., Pallmann, P., & Jaki, T. (2025). Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance. Statistics in Medicine. https://doi.org/10.1002/sim.70202
Vancouver
Robertson DS, Burnett T, Choodari-Oskooei B, Dimairo M, Grayling M, Pallmann P, et al. Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance. Statistics in Medicine. 2025. doi:10.1002/sim.70202
BibTeX
@article{Robertson2025,
author = {Robertson, David S and Burnett, Thomas and Choodari-Oskooei, Babak and Dimairo, Munya and Grayling, Michael and Pallmann, Philip and Jaki, Thomas},
title = {Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70202}
}
EUVIMED